Impact For Patients: Patient-Reported Outcome Consortium Impact For Patients: Patient-Reported Outcome Consortium Patient-Reported Outcome (PRO) Consortium helps to provide drug developer
Drug Repurposing Provides Big Impact for Patients Drug Repurposing Provides Big Impact for Patients C-Path’s CDRC is positioned to inform future clinical trials for diseases
C-Path Opportunities Table In 2004, the Food and Drug Administration launched the Critical Path Initiative (CPI) to drive innovation in the scientific proces
Electronic Clinical Outcome Assessment Consortium The Electronic Clinical Outcome Assessment (eCOA) Consortium provides scientific leadership and best practice recommendations surr
Type 1 Diabetes Consortium The T1D Consortium is working to qualify islet autoimmunity antibodies as prognostic biomarkers to be used in the development of t
July 15, 2021-July 26, 2021 VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Critical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Cons
September 19, 2024 C-Path’s PKD Outcomes Consortium Receives BAA Award for Project to Advance Drug Development Tools for Autosomal Dominant Tubulointerstitial Kidney Disease C-Path is thrilled to announce its PKDOC has been awarded...
October 16, 2023 Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.
April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
November 3, 2021 WEBINAR | Biomarkers of Effect: Safety Biomarkers as Disease Biomarkers When: November 3, 2021 – 10 a.m. US ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi